Exin Therapeutics LinkedIn · May 2026
Company post announcing Ivan Lazarte’s ASGCT 2026 poster on circuit-centric gene therapy for epilepsy.
AI drug discovery platform for neurotherapeutics
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Exin Therapeutics is a South San Francisco–based biotechnology startup building an AI discovery platform for neurotherapeutics. It focuses on neural-circuit-targeted therapies, using multimodal mouse data and machine learning to prioritize candidates for disorders such as epilepsy, autism-related epilepsies, and Parkinson’s disease.
Primary product
AI discovery platform for neurotherapeutics
Founded
2024
Headquarters
1 Tower Place, South San Francisco, CA 94080, USA
Team size
1-10
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
AI drug discovery / neurotherapeutics
Offices
Open Positions
0 jobs at Exin Therapeutics
No open positions
Check back later for new openings